Sero-Prevalence and Incidence of A/H1N1 2009 Influenza Infection in Scotland in Winter 2009–2010

Vaccine effectiveness in pandemic influenza – primary care reporting (VIPER): an observational study to assess the effectiveness of the pandemic influenza A (H1N1)v vaccine.

(2014) CR Simpson et al.   HEALTH TECHNOLOGY ASSESSMENT

Evaluation of Serological Diagnostic Methods for the 2009 Pandemic Influenza A (H1N1) Virus

(2011) Jesse Papenburg et al.   Clinical and Vaccine Immunology

Age-Specific Incidence of A/H1N1 2009 Influenza Infection in England from Sequential Antibody Prevalence Data Using Likelihood-Based Estimation

(2011) Marc Baguelin et al.   PLoS One

Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study

(2010) Elizabeth Miller et al.   LANCET

Seroprevalence Following the Second Wave of Pandemic 2009 H1N1 Influenza in Pittsburgh, PA, USA

(2010) Shanta M. Zimmer et al.   PLoS One

Influenza A (H1N1) 2009 Antibodies in Residents of New South Wales, Australia, after the First Pandemic Wave in the 2009 Southern Hemisphere Winter

(2010) Gwendolyn L. Gilbert et al.   PLoS One

Serological Response in RT-PCR Confirmed H1N1-2009 Influenza A by Hemagglutination Inhibition and Virus Neutralization Assays: An Observational Study

(2010) Mark I. Chen et al.   PLoS One

Risk Factors and Immunity in a Nationally Representative Population following the 2009 Influenza A(H1N1) Pandemic

(2010) Don Bandaranayake et al.   PLoS One

Studies Needed to Address Public Health Challenges of the 2009 H1N1 Influenza Pandemic: Insights from Modeling

(2010) Maria D. Van Kerkhove et al.   PLOS MEDICINE

Managing and Reducing Uncertainty in an Emerging Influenza Pandemic

(2009) Marc Lipsitch et al.   NEW ENGLAND JOURNAL OF MEDICINE